Martin H Bluth
Wayne State University School of Medicine, USA
Title: The case for urine toxicology testing in clinical trials
Biography
Biography: Martin H Bluth
Abstract
Urine drug testing (UDT) has conventionally been applied to the clinical domain of pain management. In such cases, adherence to narcotic analgesic administration has become a staple of drug monitoring, patient compliance and provides objective ancillary support which synergizes with the history and physical and ideally serves to empower the physician patient relationship. In concert, the opioid epidemic has changed the landscape of clinical treatment approaches. Side effects of pharmaceuticals affect drug launch, recalls and post market economics. To this end, laboratory toxicology and drug testing can identify unreported narcotic analgesics that may contribute to the safety and efficacy of clinical trial logic and results.